Vaccines for Influenza

Effie-Photini Tsilibary^{1

2}, Spyros A Charonis^{1

2}, Apostolos P Georgopoulos^{1

2}

Affiliations

¹ Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN 55417, USA.
² Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Editorial

Effie-Photini Tsilibary et al. Vaccines (Basel). 2021.

. 2021 Jan 14;9(1):47.

doi: 10.3390/vaccines9010047.

Effie-Photini Tsilibary^{1

2}, Spyros A Charonis^{1

2}, Apostolos P Georgopoulos^{1

2}

¹ Brain Sciences Center, Department of Veterans Affairs Health Care System, Minneapolis, MN 55417, USA.
² Department of Neuroscience, University of Minnesota Medical School, Minneapolis, MN 55455, USA.

Abstract

Two reviews by Harding and Heaton [...].

The authors declare no conflict of interest.

1. Harding A.T., Heaton N.S. Efforts to Improve the Seasonal Influenza Vaccine. Vaccines. 2018;6:19. doi: 10.3390/vaccines6020019. - DOI - PMC - PubMed
1. Lewnard J.A., Cobey S.E. Immune History and Influenza Vaccine Effectiveness. Vaccines. 2018;6:28. doi: 10.3390/vaccines6020028. - DOI - PMC - PubMed
1. Polack F.P., Thomas S.J., Kitchin N., Absalon J., Gurtman A., Lockhart S., Perez J.L., Marc G.P., Moreira E.D., Zerbini C., et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N. Engl. J. Med. 2020;383:2603–2615. doi: 10.1056/NEJMoa2034577. - DOI - PMC - PubMed
1. Anderson E.J., Rouphael N.G., Widge A.T., Jackson L.A., Roberts P.C., Makhene M., Chappell J.D., Denison M.R., Stevens L.J., Pruijssers A.J., et al. mRNA-1273 Study Group. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N. Engl. J. Med. 2020;383:2427–2438. doi: 10.1056/NEJMoa2028436. - DOI - PMC - PubMed
1. Chen J.-R., Liu Y.-M., Tseng Y.-C., Ma C. Better influenza vaccines: An industry perspective. J. Biomed. Sci. 2020;27:33. doi: 10.1186/s12929-020-0626-6. - DOI - PMC - PubMed